V.V. Fomin
Opening remarks
|
|
Voznesenskaya T.G.
TREATMENT OF DEPRESSION IN NEUROLOGIC DISEASES
|
9-13 |
I.S.Preobrazhenskaya
MILD TO MODERATE COGNITIVE IMPAIRMENT – CLINICAL MANIFESTATIONS, ETIOLOGY, PATHOGENESIS, AND POTENTIALS FOR THE USE
|
14-18 |
V.M. Studenikin, V.I. Shelkovsky, L.M. Kuzenkova
TIC DISORDERS AND THE ROLE OF AMINOPHENYL-BUTYRIC ACID IN THEIR TREATMENT
|
20-24 |
A.S. Avedisova
OVERCOMING OF NONCOMPLIANCE IN THE THERAPY OF CHRONIC MENTAL ILLNESS
|
25-30 |
L.S.Chutko, A.V. Rozhkova, S.Yu. Surushkina
BURNOUT SYNDROME: CLINICAL VARIANTS
|
31-33 |
M.V. Ivanov, M.Yu. Shipilin, M.G. Yanushko
SCHIZOPHRENIA AND THE USE OF PSYCHOACTIVE SUBSTANCES: AN APPROACH TO THE DIAGNOSIS AND CHOICE OF ANTIPSYCHOTIC THERAPY
|
34-38 |
Yu.E. Azimova, A.N. Magomedova
HEADACHE AND MENTAL DISORDERS: A VIEW OF NEUROLOGIST AND PSYCHIATRIST
|
39-44 |
L.S. Chutko, S.Yu. Surushkina
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN
|
45-48 |
I.V. Kolykhalov
DONEPEZIL IN THE TREATMENT OF ALZHEIMER'S DISEASE
|
49-52 |
N.A. KHITROV
OSTEOARTHROSIS AND OSTEOARTHRITIS - FROM NEW VIEWS OF PATHOGENESIS TO A NEW DENOMINATION
|
53-58 |
N.N. Petrova, M.V. Ivanov, M.A. Kaleva, V.M. Chomskaya
EFFICIENCY OF COMBINED ELECTROCONVULSIVE AND NEUROLEPTIC THERAPY IN THE OVERCOMING OF RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA
|
59-63 |